The role of clopidogrel and acetylsalicylic acid in the prevention of early-phase graft occlusion due to reactive thrombocytosis after coronary artery bypass operation

Heart Surgery Forum

Volumn 11, Issue 3, 2008, Pages 137-142

  Kayacioglu, Ilyas ^a   Gunay, Rafet ^a,b   Saskin, Huseyin ^a   Idiz, Mustafa ^a   Sensoz, Yavuz ^a   Ates, Mehmet ^a   Tangurek, Burak ^a   Alper, Ahmet Taha ^a   Demirtas, Mahmut Murat ^a   Yekeler, Ibrahim ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; EXERCISE TEST; FEMALE; FOLLOW UP; GRAFT OCCLUSION; GRAFT PATENCY; HUMAN; INCIDENCE; LABORATORY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOSIS; CORONARY ARTERY BYPASS GRAFT; MIDDLE AGED; TREATMENT OUTCOME;

ASPIRIN; CORONARY ARTERY BYPASS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; THROMBOCYTOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 46049099572     PISSN: 10983511     EISSN: None     Source Type: Journal    
DOI: 10.1532/HSF98.20071196     Document Type: Article

References (20)

1. Ainsworth BE, Haskell WL, Whitt MC, et al. 2000. Compendium of physical activities and update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498-504.
2. Blatt DL, Chew DP, Hirsh AT, Ringleb PA, Hacke W, Topol EJ. 2001. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation 103:363-8.
3. Bruce RA, Kussumi F, Hosmere D. 1973. Maximal oxygen intake and normographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 85:546-62.
4. CAPRIE Steering Committee. 1996. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329-39.
5. Chesebro JH, Clements IP, Fuster V, et al. 1982. A platelet-inhibitor- drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med 307:73-8.
6. Christenson JT, Gras PA, Grosclaude A, Simonet F, Schmuziger M. 1996. Reactive thrombocytosis following coronary artery bypass surgery: a possible link to a lipid dysfunction. J Cardiovasc Surg (Torino) 37:491-8.
7. CURE Trial Investigators. 2001. Effects of clopidogrel addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494-502.
8. FitzGibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. 1996. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 28:616-26.
9. FitzGibbon GM, Leach AJ, Keon WJ, Burton JR, Kafka HP. 1986. Coronary bypass graft fate: angiographic study of 1,179 vein grafts early, one year, and five years after operation. J Thorac Cardiovasc Surg 91:773-8.
10. Goldman S, Copeland J, Moritz MI, et al. 1988. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation 77:1324-32.
11. Johnson WD, Brenowitz JB, Kayser KL. 1989. Factors influencing long-term (10-year to 15-year) survival after a successful coronary artery bypass operation. Ann Thorac Surg 48:19-25.
12. Lichtlen PR, Nikutta P, Jost S, Deckers J, Wiese B, Rafflenbeul W. 1992. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated quantitated coronary angiography: relation to clinical events and risk factors. The INTACT Study Group. Circulation 86:828-38.
13. Lorenz RL, Scharky CV, Weber M, et al. 1984. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily): effects on platelet aggregation and thromboxane formation. Lancet 1:1261-4.
14. McKenzie FN, Dhall DP, Arfors KE, Nordlung S, Matheson NA. 1969. Blood platelet behaviour during and after open-heart surgery. Br Med J 2:795-8.
15. Messinezy M, Westwood N, Sawyer B, et al. 1994. Primary thrombocythaemia: a composite approach to diagnosis. Clin Lab Haematol 16:139-48.
16. Motwani JG, Topol EJ. 1998. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97:916-31.
17. Packham MA, Mustard JF. 1986. The role of platelets in the development and complications of atherosclerosis. Semin Hematol 23:8-26.
18. Quinn MJ, Fitzgerald DJ. 1999. Ticlopidine and clopidogrel. Circulation 100:1667-72.
19. Roberts AJ, Spies SM, Sanders JH, et al. 1981. Serial assessment of left ventricular performance following coronary artery bypass grafting: early postoperative results with myocardial protection afforded by multidose hypothermic potassium crystalloid cardioplegia. J Thorac Cardiovasc Surg 81:69-84.
20. Schmuziger M, Christenson JT, Maurice J, Simonet F, Velebit V. 1995. Reactive thrombocytosis after coronary bypass surgery: an important risk factor. Eur J Cardiothorac Surg 9:393-8.